This Day On The Street
Continue to site
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here

Thomson Reuters Introduces Infection Xpert To Improve Infection Prevention Workflow And Help Reduce Hospital-Acquired Infections

ANN ARBOR, Mich., Oct. 11, 2011 /PRNewswire/ --Thomson Reuters, a global provider of information for healthcare professionals, has launched Infection Xpert — a clinical intelligence dashboard that helps infection preventionists (IPs) manage and reduce hospital-acquired infections (HAIs), capture and submit mandated infection reporting metrics, and analyze hospital infection data to improve patient safety.  

Infection Xpert delivers critical information and functionality in a single dashboard:
  • Automated surveillance of real-time clinical data to identify patients at risk of or with a new infection.
  • Collection and reporting of data about CDC-defined HAI events.
  • Data visualizations.
  • Integrated, patient-specific Micromedex® clinical reference content.

Infection Xpert uses evidence-based clinical decision support (CDS) rules to identify medical threats earlier. For example, the tool automatically identifies patients exhibiting signs of a serious infection and in need of immediate attention. More than 70 hospitals now use this technology to monitor patients in real-time for high-risk conditions.

The Infection Xpert solution includes a library of pre-built CDS rules developed using Micromedex evidence-based reference processes. These rules cover high-priority categories such as multi-drug resistant organisms, clostridium difficile infection, methicillin-resistant staphylococcus aureus infection, and CDC-defined HAIs such as central line-associated bloodstream infection.

Using data aggregated from disparate information systems throughout the hospital, Infection Xpert presents IPs with a single view of comprehensive data about their patients, including critical lab values, medication lists, vital signs, microbiology reports, demographics, transcribed reports and more. With Infection Xpert, they can submit, collect and report National Healthcare Safety Network event and denominator data.

The IP also can access patient-specific Micromedex reference information with a single click.  With real-time access to this comprehensive patient data and reference content, IPs are equipped with all the information they need to make fully informed treatment decisions. 

"I am very excited about Infection Xpert, our latest Intelligent Evidence offering," said Thomas Hegelund, executive vice president at Thomson Reuters. "By integrating Micromedex clinical content with our Clinical Xpert™ surveillance platform, we insert the right information into the clinician's workflow.

"For example, Infection Xpert applies a large number of rules to constantly query our real-time clinical data repository, achieving ongoing patient monitoring focused on infection prevention," he said. "This is fascinating technology that meets the needs of hospitals addressing patient safety priorities, as well as reporting demands and reimbursement issues."

1 of 2

Check Out Our Best Services for Investors

Action Alerts PLUS

Portfolio Manager Jim Cramer and Director of Research Jack Mohr reveal their investment tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
Stocks Under $10

David Peltier uncovers low dollar stocks with serious upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
14-Days Free
Only $9.95
14-Days Free
Dividend Stock Advisor

David Peltier identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Updates with exact steps to take - BUY, HOLD, SELL
Trifecta Stocks

Every recommendation goes through 3 layers of intense scrutiny—quantitative, fundamental and technical analysis—to maximize profit potential and minimize risk.

Product Features:
  • Model Portfolio
  • Intra Day Trade alerts
  • Access to Quant Ratings
Real Money

More than 30 investing pros with skin in the game give you actionable insight and investment ideas.

Product Features:
  • Access to Jim Cramer's daily blog
  • Intraday commentary and news
  • Real-time trading forums
Only $49.95
14-Days Free
14-Days Free
AAPL $93.74 -1.15%
FB $117.58 0.73%
GOOG $693.01 0.29%
TSLA $240.76 -2.81%
YHOO $36.60 0.03%


Chart of I:DJI
DOW 17,773.64 -57.12 -0.32%
S&P 500 2,065.30 -10.51 -0.51%
NASDAQ 4,775.3580 -29.9330 -0.62%

Free Reports

Top Rated Stocks Top Rated Funds Top Rated ETFs